Biobattery / Biogenerator for In-Vivo Application

Award Information
Agency: Department of Energy
Branch: N/A
Contract: DE-FG02-07ER86307
Agency Tracking Number: 83239
Amount: $97,135.00
Phase: Phase I
Program: STTR
Awards Year: 2007
Solicitation Year: 2007
Solicitation Topic Code: 51 c
Solicitation Number: DE-PS02-06ER06-30
Small Business Information
696 Amity Road, Route 63, Bethany, CT, 06524
DUNS: 783630189
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Simon Levinson
 Dr
 (303) 724-1544
 Rock.Levinson@uchsc.edu
Business Contact
 Joseph Bango
Title: Dr
Phone: (203) 393-9666
Email: jbango@ctanalytical.com
Research Institution
 University of Colorado
 Jennifer E Silverthorne
 P.O. Box 6508
Aurora, CO, 80045
 Nonprofit college or university
Abstract
A growing number of electronic devices are being implanted in patients to treat a wide range of maladies. While these devices are becoming increasingly sophisticated and complex, they are powered by conventional chemical batteries with limited operating life and power output. These conventional batteries are essentially self-contained electrochemical reactors, and the total power they can produce is limited by the amount of reactants contained within them. When incorporated in implanted biomedical devices, such as cardiac pacemakers, the life of these batteries is limited to a few years. Replacement requires the surgical removal of the spent battery, often along with the entire device that it services. To address the expense and risk of replacing conventional implanted power sources, a number of groups are engaged in the development of so-called biobatteries, which would be implantable in the host and use host metabolites as chemical fuel. These devices are actually fuel cells, in which either live bacteria or immobilized enzymes convert biological substrates (e.g., glucose) to electrical energy in redox reactions. While progress has been made in demonstrating adequate power output from these devices, the issue of battery life remains a major problem. This project will develop technology for producing electric power by mimicking ion-transporting tissues that are present in nature. This biogenerator would be comprised of living, cultured, electricity-generating cells and would utilize chemical metabolites produced by the host to generate electrical power in the same manner as muscle cells and neurons, offering the potential of an inexhaustible power source. Commercial Applications and other Benefits as described by the awardee: Commercial applications would include pacemakers, cochlear implants, insulin pumps, vagal nerve stimulators, artificial retinas and cochleas, and many other implantable biomedical devices now under development. The potential market is quite large and is forecast to grow steadily as the US population ages.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government